Добірка наукової літератури з теми "Cellules souches – Droit"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Cellules souches – Droit".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Cellules souches – Droit":
Thibert, Jean-Baptiste. "Les personnes vulnérables et le don de cellules souches hématopoïétiques̊: état du droit et place de la greffe haplo-identique." Transfusion Clinique et Biologique 24, no. 3 (September 2017): 372. http://dx.doi.org/10.1016/j.tracli.2017.06.288.
Di Pietro, Giancarlo, and Jacques Beaulne. "Élodie Petit, Cellules souches embryonnaires : droit, éthique et convergence, Montréal, Éditions Thémis, 2003, 147 pages, ISBN 2-89400-169-X Alain Roy, Le contrat de mariage réinventé, Perspectives socio-juridiques pour une réforme, Montréal, Les Éditions Thémis, 2002, 455 pages, ISBN 2-89400-149-5." Revue générale de droit 34, no. 2 (2004): 387. http://dx.doi.org/10.7202/1027259ar.
Madanamoothoo, Allane. "Chapitre 14. L’intérêt et la conservation des cellules souches du sang de cordon : approche comparative des droits anglais et français." Journal international de bioéthique et d'éthique des sciences 26, no. 3 (2015): 199. http://dx.doi.org/10.3917/jib.262.0199.
Дисертації з теми "Cellules souches – Droit":
Altavilla, Annagrazia. "La recherche sur les cellules souches : enjeux éthiques et juridiques pour l'Europe." Thesis, Aix-Marseille 2, 2011. http://www.theses.fr/2011AIX20703.
Research on stem cells, challenges for of a future regenerative medicine, is emblematic of the opportunities related to scientific progress and the new questions that it implies for society. Research on human embryo, therapeutic cloning and reproductive cloning are burning issues.What are scientific, ethical, economic and legal aspects of this research at stake? Looking for a balance between the respect of the dignity of the human being and the freedom of research, in spite of the disparity of national practices and legislations, Europe became the framework for the development of a new legal corpus. This study aims at showing how the controversy related to research on stem cells come within “a European political adventure” in which individuals, institutions and public authorities, engaged in a process of “open decision”, are implied. In a comparative, multidisciplinary and trans-disciplinary perspective, this work has the objective to highlight the evolution and functioning of the European law of bioethics and especially to reveal the process which brought to the adoption of European rules in this field. The importance of this new sector of law for Europe, called to face the new scientific, economic and society challenges, is also emphasized
Perez, Castiglioni Monica Patricia. "Le statut juridique des cellules souches : de la greffe d’organes à la thérapie cellulaire." Electronic Thesis or Diss., Paris 8, 2021. http://www.theses.fr/2021PA080048.
Stem cells as cellular products for therapeutic purposes (PCT) or as advanced therapy drugs (ITNs) within the framework of regenerative medicine have revolutionized the medicine of the 21st century. Faced with recent discoveries of new stem cells created by researchers (parthenotes, cloned stem cells, iPS cells), other possibilities for regenerative therapy are emerging over time.The law, which has always accompanied the scientific and technical development of cell therapy since the 17th century, must be more present than ever to protect human beings who lend themselves to new treatments or to experimentation. The historical development of this therapeutic revolution allows us to show the importance of legal and ethical reflection for scientific progress.Old questions, such as the status of the prenatal being and the authorization for cryopreservation of autologous tissues or cells, are re-emerging in the face of the presence of supernumerary human embryonic stem cells and the success of regenerative therapy. Teratogenic treatments and episodes of child abuse during pregnancy have destroyed or damaged thousands of unborn children. Recognition of prenatal life is offered in certain circumstances to protect the embryo and fetus before birth
Achmaoui, Hafida. "L'embryon être ou ne pas être : évolution ou révolution ?" Paris 8, 2007. http://www.theses.fr/2007PA083037.
As ancient as intense, the debate on the judicial statute on the human embryo has known for the last thirty years a significant revival of relevance: there is just a few subjects that can claim/ boast to have aroused as much discussions as this one. The profusion of the reports, debates on the topic is enough to show it. Indeed, in the absence of an equivalent statute generating a scheme of protection, the legislator undertook to frame the various practices which could be carried out on the embryo. However, the current intervention of the legislator is likely to modify many aspects of the protective framework established in 1994, in favor of a liberalization of the possibilities of research on the embryo. In view of new but more and more attractive stakes, the arguments of the partisans of a liberalization of research on certain categories of embryos weigh each day more. However, it is necessary to analyze in all objectivity the various stakes of a liberalization of the research, and not to be carried away by therapeutic, often hypothetical promises. These clarifying statements underline already the extent of the questionings attached to the study of the embryo, its statute, its place in research. If these multiple questionings translate the unrest of a society whose rules relating to the embryo are seen regularly set in question, they underline especially the absence of an explicit statute whose existence could have offered to the embryo the guarantee of a reliable scheme of protection
Lambert, Virginie. "Thérapie cellulaire par progéniteurs cardiaques issus de cellules souches embryonnaires dans un modèle porcin de dysfonction ventriculaire droite par surcharge chronique." Paris 5, 2009. http://www.theses.fr/2009PA05P639.
The long term prognosis of some congenital heart diseases may be impaired related to severe right ventricular (RV) dysfunction and conventional therapies give poor results. Cell therapy may be an alternative therapeutic approach. The aims of this study were 1/ to create an experimental model of RV dysfunction secondary to chronic overload as observed in congenital heart diseases, 2/ to apply on this failed RV a cell therapy using cardiac progenitors derived from human embryonic stem cells. We have characterized in a large animal a model of RV dysfunction secondary to a combined chronic overload using a surgical procedure reproducing the RV outflow tract diseases as observed after repair in tetralogy of Fallot. After 4 months, we have observed the various aspects of RV dysfunction: hemodynamic with an impairment of myocardial contractility, electrophysiological with an increasing of duration of both QRS and action potential and histological with a myocardial remodelling at the first stage. In this model of RV dysfunction, we have applied cell therapy and injected into multiple sites of RV myocardium cardiac progenitors derived from human embryonic stem cells. We have observed an improvement of myocardial contractility and a stabilization of the deleterious effects of the chronic overload on cardiac function. No ventricular arrhythmia occurred and no teratoma was detected. This first attempt of cell therapy using cardiac progenitors is encouraging and may be an interesting innovative approach to treat RV dysfunction secondary to chronic overload
Chrétien, Joséane. "Sang ombilical et placentaire : enjeux juridiques propres au consentement et au droit de propriété." Thèse, 2016. http://hdl.handle.net/1866/19142.
The umbilical and placental cord blood is now a prized biological resource as it contains stem cells and high hemoglobin level used in therapeutic treatments. Considering the current applications and those envisaged in the future, cord blood can be secured in private banking for autologous or family use. It can also be given to a public bank for allogeneic transplants or research. Cord blood should not be considered as a human waste without value, even if it is inevitably produced at the time of birth of each child. Consent must be obtained before any withdrawal and use. This study presents an empirical review of Canadian cord blood banking practice. This analysis reveals that banks do obtain prior consent to the collection, storage and use of cord blood. However, the source of this consent differs. It also shows that the actors involved in the banking process consider cord blood as a movable property that can be transferred to one another. This study addresses the question of who, between the mother and the child, should consent to cord blood collection and storage. It deals with blood’s ownership once separated from the human body and the legal constraints applicable to its alienation and use. It also suggests modifications to the legal framework for cord blood research as well as a standardization of private storage rules.
Benoit, Stéphanie. "La mise en marché des produits issus du génie tissulaire: Une question de catégorisation?" Thèse, 2008. http://hdl.handle.net/1866/3987.
Tissue engineering is an interdisciplinary field that applies the principles of engineering and the life sciences (including the science of stem cells) toward the development of biological substitutes that restore, maintain or improve tissue function. In other words, rather than being replaced, tissues and organs are repaired. Research in tissue engineering is important and ambitions are high, such as ending the waiting list for organ transplant. Tissue engineering has already started delivering therapeutic products for simple applications such as skin and cartilage. Questions on the way tissue engineered therapeutic products are regulated are raised with each new product. Until now, these questions have been given little attention compared to the ethical issues related to stem cell research and to the risks generated by biologics. It is therefore important to examine whether the regulatory framework is suitable since some tissue engineered products are already available on the market and others are soon to be marketed. Our analysis reveals that the Canadian regulatory framework is not suitable and the time is ripe for reform. The United States and the European Union have their own approaches that are instructive. We have undertaken a study of the regulatory premarket approval frameworks in Canada, United States and the European Union, and formulated suggestions for reform.
Книги з теми "Cellules souches – Droit":
Petit, Elodie. Les cellules souches embryonnaires: Droit,éthique et convergence. Montréal, Québec: Editions Thémis, 2003.
Desnos, Michel. Faut-il autoriser le clonage scientifique?: Les enjeux de la recherche sur les cellules souches. Paris: La Documentation française, 2006.
Instituts de recherche en santé du Canada. Recherche sur les cellules souches humaines: La santé dans un cadre éthique : document de travail. Ottawa, Ont: Instituts de recherche en santé du Canada, 2001.
Canadian Institutes of Health Research. Human stem cell research: Opportunities for health and ethical perspectives : a discussion paper. Ottawa: Canadian Institutes of Health Research, 2001.
Частини книг з теми "Cellules souches – Droit":
Pauwels, Éléonore. "Éthique et droits fondamentaux européens : les enjeux de la recherche sur les cellules souches embryonnaires." In Traité de bioéthique, 327. ERES, 2010. http://dx.doi.org/10.3917/eres.hirsc.2010.01.0327.